Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "The RIGHT Choice Trial - 1L Ribociclib + ET vs. Combination Chemo in Aggressive HR+/HER2- Advanced Breast Cancer"

391 views
November 14, 2023
Comments 0
Login to view comments. Click here to Login